Personalis Q3 revenue rises to $25.6 million; net loss widens to $33.8 million
Personalis reported third-quarter 2026 revenue of $25.6 million, up from $14.5 million a year earlier, while its net loss widened to $33.8 million, or $0.32 per share, from $21.7 million, or $0.24 per share. The company will no longer provide financial guidance or hold quarterly earnings calls because of the merger agreement with Tempus AI, Inc. announced July 20, 2026.
Key points
- Revenue of $25.6 million vs. $14.5 million a year earlier; clinical test revenue of $4.4 million vs. $0.4 million.
- Net loss of $33.8 million, or $0.32 per share, vs. $21.7 million, or $0.24 per share, a year earlier.
- Cash, cash equivalents and short-term investments of about $190.6 million as of September 30, 2026.
- No full-year 2026 guidance, as a result of the Tempus AI merger agreement announced July 20, 2026.
The filing
Written by AI on Nov 9, 2026, 8:38 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 04, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.